Pfizer reports patient death in Duchenne gene therapy study Pfizer's gene therapy trial for Duchenne muscular dystrophy resulted in a young patient's death from cardiac arrest The Hindu · May 8, 2024
3 Standout Penny Stocks to Watch This April Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according to Wall Street. Barchart · Apr 16, 2024
Gene Therapy Breakthroughs In The 1990S Revolutionized Medical Treatment. Explore the pivotal era of gene therapy in the 1990s, from groundbreaking advancements to significant challenges, shaping modern regenerative medicine. Top News · Mar 31, 2024
Kyowa Kirin's Gene Therapy: Most Expensive US Drug Kyowa Kirin's .3 million gene therapy sparks debates on accessibility and affordability in healthcare. Top News · Mar 20, 2024
Kyowa Kirin Gene Therapy: Most Expensive US Drug At .3M Kyowa Kirin's .3 million gene therapy sparks debate on accessibility and pricing of innovative treatments in the US. Top News · Mar 20, 2024
Ensuring Quality Control In Cell And Gene Therapy Manufacturing Learn about the importance of quality control in cell and gene therapy manufacturing for patient safety and market success. Top News · Feb 29, 2024
German firm Miltenyi Biotec opens office, plans Cell and Gene Therapy CoE Miltenyi Biotec launches operations in Hyderabad, investing in a Cell and Gene Therapy centre of excellence. The Hindu · Feb 27, 2024
Exploring The Top 10 Genetic Engineering Breakthroughs Explore the latest breakthroughs in genetic engineering, from CRISPR-Cas9 to gene therapy, and their impact on healthcare and conservation. Top News · Feb 23, 2024
Heart Attack: Gene therapy improves advanced heart failure in animal model During a heart attack, blood stops flowing into the heart. Without oxygen, a portion of the heart muscle dies. Read further on Dynamite News: Dynamite News · Feb 14, 2024
Gene therapy may slow progression of a life-threatening cardiac ailment The investigational treatment targets the loss of function of a gene implicated in many cases of ARVC, plakophilin-2 (PKP2). Read further on Dynamite News: Dynamite News · Feb 5, 2024
Gene therapy hailed as ‘medical magic wand’ for hereditary swelling disorder Single-dose treatment transformed lives of patients with potentially deadly condition in first human trial The Guardian - UK · Jan 31, 2024
Gene therapies restore hearing in several kids with inherited deafness Two new gene therapies show promise in treating otoferlin-related deafness, an inherited condition. LiveScience · Jan 24, 2024
Gene therapy shows promise for an inherited form of deafness Scientists report that gene therapy restored at least some hearing and speech for five out of six children with a rare form of genetic deafness. WEKU · Jan 24, 2024
Deaf Boy Can Now Hear After Breakthrough Gene Treatment His father's voice, the sounds of passing cars and scissors clipping his hair: An 11-year-old boy is hearing for the first time in his life after receiving a breakthrough gene therapy. International Business Times · Jan 23, 2024
Inverse · Dec 29, 2023 We Are About to Enter the Golden Age of Gene Therapy The discovery of CRISPR has allowed us to enter a new era of disease treatment. Here’s what 2024 and beyond has in store for our gene-edited future.
Evening Standard · Dec 21, 2023 'It could change lives': Inside London lab testing gene therapy for cancer and obesity Meira GTx, in Shoreditch, is working on potentially revolutionary treatments for a wide array of illnesses
Fortune · Dec 21, 2023 Bryan Johnson is being used as a human guinea pig in unproven tests to reprogram human genes in an island off Honduras At $25,000 a go, the gene therapy works by turbocharging the body’s production of follistatin. It is, according to Minicircle Inc, the small US startup behind the therapy one of humanity’s best hopes for “extreme longevity”.
Evening Standard · Dec 15, 2023 New gene therapy 'significantly reduces seizures' for children with epilepsy UCL expect to begin human trials of therapy within five years
The Independent UK · Dec 14, 2023 Promising new gene therapies for sickle cell are out of reach in countries where they're needed most New gene therapies promise a cure for sickle cell disease but experts say they are out of reach in places that need them the most
The Hindu · Dec 12, 2023 Game-changer: On approval for gene therapy to treat sickle cell disease and beta thalassemia Landmark decisions that mark the beginning of gene therapy using the CRISPR-Cas9 tool to treat diseases that could otherwise be cured only through bone marrow transplantation
Inverse · Nov 16, 2023 The First CRISPR Gene Therapy Was Finally Approved In The US — Here’s How It Works Using the gene editing tool CRISPR, the new therapy promises a cure for those with sickle cell anemia and beta thalassemia, but cost could be a barrier to care.
The Independent UK · Nov 16, 2023 UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K. In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it had approved Casgevy, the…
The Independent UK · Nov 16, 2023 Blood disorder breakthrough as world-first gene therapy given green light The treatment is the first to be licensed using the gene-editing tool known as Crispr, for which its inventors were awarded the Nobel prize in 2020
Evening Standard · Nov 16, 2023 Casgevy: World-first gene therapy for sickle cell disease approved in UK Regulator's approval comes three years after scientists won Nobel Prize for inventing the treatment
The Independent UK · Nov 16, 2023 World-first gene therapy for inherited blood disorders approved in UK The treatment is the first to be licensed using the gene-editing tool known as Crispr, for which its inventors were awarded the Nobel prize in 2020.